Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Short interest

<< Previous

Bullboard Posts

Next >>

Comment by Hoover69on May 20, 2022 8:51am

98 Views

Post# 34697763

RE:Short interest

Your desperation is obvious. 1.6 mio shares is less than half a percent of all shares outstanding and is worth a whopping $96,000 based on current market value. No one needs to cover and in fact the shorts actually went up from March to April. This is a dog!

Golddetector wrote: We have close to 1.6M short to be covered as of May 14. You can see the support below 6c mostly trying to cover and resistance above 7c by shorts trying to keep sp under control. Good news recent funds coming without extra shares to the open market. GL longs.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide